Search Results - "Baillet, M."

Refine Results
  1. 1

    Heightened response of eosinophilic asthmatic patients to the CRTH2 antagonist OC000459 by Pettipher, R., Hunter, M. G., Perkins, C. M., Collins, L. P., Lewis, T., Baillet, M., Steiner, J., Bell, J., Payton, M. A.

    Published in Allergy (Copenhagen) (01-09-2014)
    “…Background The CRTH2 antagonist OC000459 has previously been demonstrated to reduce airway inflammation and improve lung function in moderate persistent…”
    Get full text
    Journal Article
  2. 2

    A double-blind placebo-controlled, randomised study comparing gemcitabine and marimastat with gemcitabine and placebo as first line therapy in patients with advanced pancreatic cancer by BRAMHALL, S. R, SCHULZ, J, NEMUNAITIS, J, BROWN, P. D, BAILLET, M, BUCKETS, J. A. C

    Published in British journal of cancer (15-07-2002)
    “…Pancreatic cancer is the fifth most common cause of cancer death in the western world and the prognosis for unresectable disease remains poor. Recent advances…”
    Get full text
    Journal Article
  3. 3

    Marimastat as maintenance therapy for patients with advanced gastric cancer: a randomised trial by BRAMHALL, S. R, HALLISSEY, M. T, BAILLET, M, FIELDING, J. W. L, WHITING, J, SCHOLEFIELD, J, TIERNEY, G, STUART, R. C, HAWKINS, R. E, MCCULLOCH, P, MAUGHAN, T, BROWN, P. D

    Published in British journal of cancer (17-06-2002)
    “…This randomised, double-blind, placebo-controlled study was designed to evaluate the ability of the orally administered matrix metalloproteinase inhibitor,…”
    Get full text
    Journal Article
  4. 4

    Marimastat in recurrent colorectal cancer: exploratory evaluation of biological activity by measurement of carcinoembryonic antigen by PRIMROSE, J. N, BLEIBERG, H, BERRINGTON, A, BROWN, P. D, MILLAR, A. W, LYNCH, K. P, DANIEL, F, VAN BELLE, S, MANSI, J. L, SEYMOUR, M, JOHNSON, P. W, NEOPTOLEMOS, J. P, BAILLET, M, BARKER, K

    Published in British journal of cancer (01-02-1999)
    “…Marimastat is a specific inhibitor of matrix metalloproteinases that has been shown to be effective in cancer models. A pilot, escalating-dose study of oral…”
    Get full text
    Journal Article
  5. 5
  6. 6

    0281 FRONTAL Β-AMYLOID BURDEN AND SLEEP DURATION IN AGING by BAILLET, M, MEYER, M, DILHARREGUY, B, PERES, K, 
HELMER, C, DARTIGUES, J, ALLARD, M, FERNANDEZ, P, ZANOTTI-FREGONARA, P, CATHELINE, G, MAYO, W

    Published in Sleep (New York, N.Y.) (28-04-2017)
    “…Abstract Introduction: Recent studies suggest relationships between sleep disturbances and early signs of Alzheimer’s disease pathology (Spira, 2013). The aim…”
    Get full text
    Journal Article
  7. 7

    Inhibition of herpes simplex virus type 1 ribonucleotide reductase by substituted tetrapeptide derivatives by Moss, Neil, Deziel, R, Adams, J, Aubry, N, Bailey, M, Baillet, M, Beaulieu, P, DiMaio, J, Duceppe, J. S

    Published in Journal of medicinal chemistry (01-10-1993)
    “…It is known that peptides corresponding to the C-terminus of the small subunit of herpes simplex virus type 1 and 2 ribonucleotide reductase can inhibit…”
    Get full text
    Journal Article
  8. 8

    Reduced blood CD123+ (lymphoid) and CD11c+ (myeloid) dendritic cell numbers in primary HIV-1 infection by Pacanowski, Jérôme, Kahi, Sandrine, Baillet, Marjorie, Lebon, Pierre, Deveau, Christiane, Goujard, Cécile, Meyer, Laurence, Oksenhendler, Eric, Sinet, Martine, Hosmalin, Anne

    Published in Blood (15-11-2001)
    “…Successful immunologic control of HIV infection is achieved only in rare individuals. Dendritic cells (DCs) are required for specific antigen presentation to…”
    Get full text
    Journal Article
  9. 9

    Profil osseux, cognitif et anthropométrique des patients en fonction du siège de la fracture post-chute : une étude transversale by Baillet, M., Morello, R., Vittecoq, O., Chavoix, C., Marcelli, C.

    “…La densité minérale osseuse (DMO), les fonctions cognitives et l’indice de masse corporelle (IMC) pourraient jouer un rôle dans le siège des fractures…”
    Get full text
    Journal Article
  10. 10

    Heightened response of eosinophilic asthmatic patients to the CRTH 2 antagonist OC 000459 by Pettipher, R., Hunter, M. G., Perkins, C. M., Collins, L. P., Lewis, T., Baillet, M., Steiner, J., Bell, J., Payton, M. A.

    Published in Allergy (Copenhagen) (01-09-2014)
    “…Abstract Background The CRTH 2 antagonist OC 000459 has previously been demonstrated to reduce airway inflammation and improve lung function in moderate…”
    Get full text
    Journal Article
  11. 11

    Association entre les acides gras polyinsaturés oméga-3 à longue chaîne, l’atrophie cérébrale, le déclin cognitif et le risque de démence–cohorte des 3-Cités–Bordeaux by Thomas, A., Baillet, M., Proust-Lima, C., Féart, C., Helmer, C., Catheline, G., Samieri, C.

    Published in Nutrition clinique et métabolisme (01-04-2020)
    “…Les acides gras polyinsaturés oméga-3 (AGPI n-3) à longue chaîne, en particulier les acides eicosapentaénoïque (EPA) et docosahexaénoïque (DHA), sont des…”
    Get full text
    Journal Article
  12. 12

    Induction of MHC Class I Presentation of Exogenous Antigen by Dendritic Cells Is Controlled by CD4+ T Cells Engaging Class II Molecules in Cholesterol-Rich Domains by Machy, Patrick, Serre, Karine, Baillet, Marjorie, Leserman, Lee

    Published in The Journal of immunology (1950) (01-02-2002)
    “…We investigated interactions between CD4+ T cells and dendritic cells (DC) necessary for presentation of exogenous Ag by DC to CD8+ T cells. CD4+ T cells…”
    Get full text
    Journal Article
  13. 13

    MHC Class II-Peptide Complexes in Dendritic Cell Lipid Microdomains Initiate the CD4 Th1 Phenotype by Buatois, Vanessa, Baillet, Marjorie, Becart, Stephane, Mooney, Nuala, Leserman, Lee, Machy, Patrick

    Published in The Journal of immunology (1950) (01-12-2003)
    “…We investigated differentiation of CD4 T cells responding to Ag presented by bone marrow-derived dendritic cells (DC) in association with MHC class II (MHC II)…”
    Get full text
    Journal Article
  14. 14

    Induction of MHC Class I Presentation of Exogenous Antigen by Dendritic Cells Is Controlled by CD4 super(+) T Cells Engaging Class II Molecules in Cholesterol-Rich Domains by Machy, P, Serre, K, Baillet, M, Leserman, L

    Published in The Journal of immunology (1950) (01-02-2002)
    “…We investigated interactions between CD4 super(+) T cells and dendritic cells (DC) necessary for presentation of exogenous Ag by DC to CD8 super(+) T cells…”
    Get full text
    Journal Article
  15. 15

    Plasma beta-thromboglobulin in patients with valvular heart disease with or without valve replacement: relationship with thromboembolic accidents by Conard, J, Horellou, M H, Baillet, M, Terrier, E, Houllegate, J M, Farah, E, Samama, M, Acar, J

    Published in European heart journal (01-10-1984)
    “…Plasma beta-thromboglobulin (BTG) was measured in 132 patients with valvular heart disease: 43 were studied before, 89 after surgery (78 mechanical valves and…”
    Get more information
    Journal Article
  16. 16

    Downregulation of major histocompatibility class I on human dendritic cells by HIV Nef impairs antigen presentation to HIV-specific CD8+ T lymphocytes by Andrieu, M, Chassin, D, Desoutter, J F, Bouchaert, I, Baillet, M, Hanau, D, Guillet, J G, Hosmalin, A

    Published in AIDS research and human retroviruses (20-09-2001)
    “…The HIV early regulatory Nef protein downregulates surface expression of major histocompatibility class I (MHC I) molecules on various immortalized cell lines…”
    Get more information
    Journal Article
  17. 17

    Changes in serum beta-thromboglobulin levels during oral contraception, cardiac valve disease and pulmonary embolism (author's transl) by Conard, J, Terrier, E, Baillet, M, Horellou, M H, Jaulmes, B, Samama, M, Baillet, J

    Published in La Nouvelle presse medicale (11-04-1981)
    “…beta-thromboglobulin (beta TG), a platelet-specific protein, was measured in the plasma of 53 healthy subjects (20 men and 33 women), 53 women using…”
    Get more information
    Journal Article
  18. 18
  19. 19

    Novel small renin inhibitors containing 4,5- or 3,5-dihydroxy-2-substituted-6-phenylhexanamide replacements at the P2-P3 sites by Jung, G L, Anderson, P C, Bailey, M, Baillet, M, Bantle, G W, Berthiaume, S, Lavallée, P, Llinas-Brunet, M, Thavonekham, B, Thibeault, D, Simoneau, B

    Published in Bioorganic & medicinal chemistry (01-12-1998)
    “…Renin inhibitors containing a 4,5- or a 3,5-dihydroxy-2-substituted-6-phenylhexanamide fragment at the P2-P3 sites have been prepared and evaluated. The four…”
    Get full text
    Journal Article
  20. 20